How We Can Help
Each day, thousands of people are hurt because of someone else’s negligence. If you’ve been hurt from a defective drug or medical device, you need a lawyer with experience and compassion.
- Androgel - Testosterone
- Talcum Powder
- Attune Knee
If you were injured by prescription testosterone such as Androgel® you are not alone. To date thousands of lawsuits have been filed against the manufacturers of prescription testosterone over injuries that may have been caused by testosterone. The most common injuries associated with supplemental prescription testosterone use are heart attack, stroke, pulmonary embolism or deep vein thrombosis.
Some testosterone products are:
Recent medical studies show that supplemental testosterone therapy leads to an increased risk of cardiovascular injury by 30%.
Many patients in need of a blood thinning medication thought a new drug Xarelto® was the answer to their problem. Xarelto was marketed as better than warfarin, an older medication, and it did not require patients to undergo frequent blood tests. Unfortunately, however, the use of Xarelto came with a heavy price – uncontrolled bleeding and no antidote to stop the bleeding.
Individuals using Xarelto have experienced internal or gastrointestinal bleeding, brain hemorrhages, hemorrhagic strokes and death from bleeding that would not stop. According to Quarter Watch, Xarelto accounted for 10,674 serious adverse event reports in calendar year 2015 with 1,121 deaths and 4,508 injuries requiring hospitalization.
Xarelto is manufactured by Bayer AG and in calendar year 2014, Xarelto accounted for sales totaling 3.5 billion euros. For calendar year 2015, Xarelto sales increased 34% from calendar year 2014.
The story of the harm to users of Proton Pump Inhibitors (PPIs) has been hidden in medical journals for decades. It remained a secret until an article gained much needed attention in April 2016.
First, the drugs at issue include both prescription and over-the-counter medicine such as Nexium®, Prevacid®, Prilosec®, Protonix® or Aciphex®. PPIs are used to treat heart burn, acid reflux and ulcers.
The article titled, “PPIs and Kidney Injury: Longer Use Tied to Higher Risk”, Medscape, April 14, 2016. For the study researchers analyzed data from the Veterans Administration and identified 173,321 new users of PPI and 20,270 new users of H2 blocker. H2 blockers are drugs such as Tagemet®, Pepcid® or Zantax®. Both classes of drugs are used from the same medical issue. The study revealed that over the course of 5 years that patients who were prescribed PPI were 22% more likely to have a drop in their glomerular filtration rate than users of H2 blockers. In addition, users of PPI, such as Nexium, Prevacid or Prilosec were 28% more likely to develop chronic kidney disease than users of H2 blockers.
Invokana, also known as canagliflozin, was approved by the U.S. Food and Drug Administration in 2013 for treatment of people with type 2 diabetes for help with control high blood sugar. It’s an SGLT2 inhibitor, which means it works by reducing blood glucose levels. It’s manufactured by pharmaceutical powerhouse Johnson & Johnson, which touted Invokana as a breakthrough in diabetes treatment.
Unfortunately, as the Salt Lake City Invokana injury attorneys at The James Esparza Law Group know, numerous complications have come to light. Specifically, following interim clinical trials, regulators are requiring warnings on Invokana prescription labels regarding the heightened risk of leg and foot amputations (mostly affecting toes) by those who take the drug.
Some naturally-occurring talc contains asbestos, which is a known catalyst for a type of cancer called mesothelioma. However, numerous studies now assert a link between the use of talcum powder and ovarian cancer. The basis of these product liability lawsuits is that manufacturers of the powder failed to warn users of this increased risk when women used the powder for personal hygiene.
Salt Lake City talcum powder injury attorneys at The Esparza Law Group know that nearly 5,000 injury lawsuits are pending against Johnson & Johnson, which is the largest manufacturer of U.S. baby powder products with Johnson’s Baby Powder.
Some rheumatoid arthritis sufferers were excited when Actemra hit the U.S. market in 2010, following regulatory approval from the U.S. Food & Drug Administration. Genentech, a member of the Roche Group and maker of Actemra (known generically as tocilizumab), promised it would “transform expectations” for both doctors and patients. Even better, Actemra didn’t come with any warning of heart attacks, strokes and other complications, as competing drugs did. It was seemingly safer.
Today, there is a growing body of evidence to the contrary. Our best Actemra injury attorneys in Weber County at The Esparza Law Group know that since its release, Actemra has been linked to serious health complications, hospitalizations and death.
Mirena has become a popular form of birth control since it was approved by the U.S. Food and Drug Administration in 2000. Prescribed to some 2 million women in the U.S. alone, it’s medically known as an intrauterine device (IUD). It is small, plastic, shaped like a “T” and releases synthetic doses of the hormone levonorgestrel to block sperm from reaching and fertilizing eggs. The medical devices are designed as a long-term method to stop unwanted pregnancies for up to five years.
Although Mirena has been aggressively advertised as both safe and effective, The Ezparza Law Group’s Utah Mirena injury attorneys know there have been many reports of women suffering serious complications after having Mirena implanted.
Januvia tablets are a DPP-4 inhibitor, and work by upping levels of incretins, which release insulin and decrease sugar made by the liver. Another drug, Janumet, is similar, but combines Januvia with metformin for better glycemic control.
The drug has numerous listed side effects, some of them serious, and the U.S. Food and Drug Administration has investigated reports of pancreatitis and pre-cancerous cells in the pancreas by those using Januvia or Janumet. Also included in this class of drugs are Byetta and (exenatide) and Victoza (liraglutide).
Though Novo Nordisk has denied any wrongdoing in its marketing of Victoza, it was compelled to pay nearly $59 million in 2017 in a settlement with the FDA for alleged violations of the False Claims Act and the U.S. Food, Drug and Cosmetic Act. Whistleblowers alleged the company paid kickbacks and had sales people posing as medical educators.
There are nearly 1,000 pending cases in Multi-District Litigation (MDL) lawsuits pending in the U.S. District Court for the Southern District of California for incretin-based drug therapies, including Victoza, Byetta, Januvia and Janumet – with the primary side effect of these cases being pancreatic cancer.
Several new diabetes drugs have hit the market in recent years, including one called Byetta, an injectable that mimics a natural hormone called glucagon-like peptide-1 (GLP-1). This hormone increases the production of insulin and lowers blood sugar to a safe level.
However, since the U.S. Food and Drug Administration approved Byetta (generic name exenatide) in 2005, regulators have published numerous warnings, following hundreds of reports of patients suffering serious and sometimes fatal side effects, including:
- Kidney failure
- Pancreatic cancer
- Thyroid cancer
- Severe joint pain
Attune Knee implants were designed to increase range of motion and increased longevity, but the implant has been linked to premature failure requiring knee revision surgery resulting in Attune Knee lawsuits being filed across the country.
Attune® Knee implants have been failing at an unusually higher rate than expected this according to a medical journal article in Journal of Knee Surgery.
The high failure rate is alleged to occur because the knee implant was designed defectively with reduced cement pockets and reduced surface roughness. In essence, the surface is too smooth making it difficult for the medical cement to hold the implant to the patient’s tibia bone. According to the study in all tibia revision cases examined there was a complete “debonding” of the cement from the implant, while all the cement was strongly adhered to the tibia bone. The average time to revision surgery was 19 months.
The fluoroquinolones, antibiotics, is a long story of what can go wrong with what is perceived as a safe product. Common fluoroquinolones are: Avelox®, Cipro®, and Levaquin®. Fluoroquinolones (FLQ) are among the most prescribed antibiotics so adverse events can have significant public health implications for many.
The early controversy over FLQ involved tendonitis and Achilles tendon rupture. In the early 90’s medical research focused on tendon rupture. Researchers speculated that FLQ’s affected collagen in some way because tendons are composed collagen fibers. Collagen is a unique structure that is stronger than steel. It is found throughout the body in cartilage, blood vessels, the cornea, muscles and the gastrointestinal tract.
There are several types of collagen. Type I and type III collagen comprise the majority of collagen in the Achilles tendon. Approximately 90% of collagen in normal tendons is Type I and 10% is Type III. Over the years medical studies have coalesce around the proposition that FLQ interfered with collagen fibrils found in Type I collagen. Medical studies indicate discuss FLQ’s such as Cipro exert a negative effect on tendon structure or its healing process through the mechanism by up-regulating gelantinase (MMP-2) expression. According to the Tsai study, type I collagen is degraded after treatment with ciprofloxacin. Over the years fluoroquinolone tendon ruptures are a recognized complication of this class of drugs.